Tag: Co-design

Why did nobody ask us?! Reflections and findings from co-produced research into children’s vaccine uptake.

In conversation with Dr Helen Skirrow, Lena Choudary-Salter and Habiba Haque

A recap on our research project

Not enough children in the local area around Church Street, Westminster, London where the Mosaic Community Trust is based get their routine vaccines.  We therefore worked together on our project that Lena Choudary-Salter (Mosaic’s CEO) named ‘Why did nobody ask us?!’ to reflect that local parents’ views who live in an area of low vaccine uptake had not previously been listened to.  We have written about our partnership working before. Children missing out on their routine vaccines is a problem not just in Church Street but in lots of areas of London and other urban areas of the UK, which are poorer and have more ethnically diverse populations.

Developing an implant to prevent breast cancer-related lymphoedema

In conversation with: James E Moore Jr., Principal Investigator; Alain Vella, Research Engineer; and Arushri Swarup, Research Associate, from the Moore Research Group in the Department of Bioengineering, Imperial College London

What is your research project about and what stage are you at?

We have developed an implant to prevent the onset of breast cancer-related lymphoedema (BCRL). BCRL is an under-represented condition that can occur following lymph node removal for the treatment of breast cancer. When lymph nodes are removed, lymphatic vessels (small vessels that transport fluid out of tissues) are damaged. In approximately 20% of patients this can lead to fluid build-up resulting in a swollen, heavy arm negatively impacting patients’ physical and mental health.

User-centred design in diabetes technology development

In conversation with: Dr Parizad Avari, ST7 Registrar and Honorary Clinical Lecturer, working with Professor Nick Oliver in the Department of Metabolism, Digestion and Reproduction, Imperial College, London

What is your research project about and what stage are you at?

We are aiming to improve the lives of people living with Type 1 diabetes, an autoimmune condition which requires lifelong insulin therapy. The Horizon 2020 PEPPER (Patient Empowerment through Predictive PERsonalised decision support) project is a personalised decision support system to support self-management. The PEPPER app was designed for people with type 1 diabetes to manage their condition by providing personalised advice about insulin dosage and carbohydrate intake through artificial intelligence.